Acorah Software Products - Accounts Production 16.0.110 false true 28 February 2023 1 March 2022 false 1 March 2023 28 February 2024 28 February 2024 11837982 Dr V Azoidou iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11837982 2023-02-28 11837982 2024-02-28 11837982 2023-03-01 2024-02-28 11837982 frs-core:ComputerEquipment 2024-02-28 11837982 frs-core:ComputerEquipment 2023-03-01 2024-02-28 11837982 frs-core:ComputerEquipment 2023-02-28 11837982 frs-core:ShareCapital 2024-02-28 11837982 frs-core:RetainedEarningsAccumulatedLosses 2024-02-28 11837982 frs-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-28 11837982 frs-bus:FilletedAccounts 2023-03-01 2024-02-28 11837982 frs-bus:SmallEntities 2023-03-01 2024-02-28 11837982 frs-bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-28 11837982 frs-bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-28 11837982 frs-bus:OrdinaryShareClass1 2023-03-01 2024-02-28 11837982 frs-bus:OrdinaryShareClass1 2024-02-28 11837982 frs-bus:Director1 2023-03-01 2024-02-28 11837982 frs-countries:EnglandWales 2023-03-01 2024-02-28 11837982 2022-02-28 11837982 2023-02-28 11837982 2022-03-01 2023-02-28 11837982 frs-core:ShareCapital 2023-02-28 11837982 frs-core:RetainedEarningsAccumulatedLosses 2023-02-28 11837982 frs-bus:OrdinaryShareClass1 2022-03-01 2023-02-28
Registered number: 11837982
Vestibular & Neurological Therapy Ltd
Unaudited Financial Statements
For The Year Ended 28 February 2024
Finsbury Robinson Ltd
237 Westcombe Hill
London
SE3 7DW
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 11837982
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 482 643
482 643
CURRENT ASSETS
Debtors 4,497 3,871
Cash at bank and in hand 175 672
4,672 4,543
Creditors: Amounts Falling Due Within One Year (5,029 ) (5,049 )
NET CURRENT ASSETS (LIABILITIES) (357 ) (506 )
TOTAL ASSETS LESS CURRENT LIABILITIES 125 137
NET ASSETS 125 137
CAPITAL AND RESERVES
Called up share capital 5 100 100
Profit and Loss Account 25 37
SHAREHOLDERS' FUNDS 125 137
Page 1
Page 2
For the year ending 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr V Azoidou
Director
8th November 2024
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Vestibular & Neurological Therapy Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11837982 . The registered office is 237 Westcombe Hill, London, SE3 7DW.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 25% on reducing balance
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
Tax is recognised in the profit and loss account except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
Deferred Tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the Balance Sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
Page 3
Page 4
4. Tangible Assets
Computer Equipment
£
Cost
As at 1 March 2023 875
As at 28 February 2024 875
Depreciation
As at 1 March 2023 232
Provided during the period 161
As at 28 February 2024 393
Net Book Value
As at 28 February 2024 482
As at 1 March 2023 643
5. Share Capital
2024 2023
Allotted, called up and fully paid £ £
100 Ordinary Shares of £ 1.00 each 100 100
Page 4